Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Si mei Shi"'
Autor:
De‐shen Wang, Zhi‐qiang Wang, Gong Chen, Jie‐wen Peng, Wei Wang, Yan‐hong Deng, Feng‐hua Wang, Jian‐wei Zhang, Han‐lin Liang, Fen Feng, Chuan‐bo Xie, Chao Ren, Ying Jin, Si‐mei Shi, Wen‐hua Fan, Zhen‐hai Lu, Pei‐rong Ding, Feng Wang, Rui‐hua Xu, Yu‐hong Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 151-159 (2020)
Abstract Background Monosialotetrahexosylganglioside (GM1) is a neuroprotective glycosphingolipid that repairs nerves. Oxaliplatin‐based chemotherapy is neurotoxic. This study assessed the efficacy of GM1 for preventing oxaliplatin‐induced periph
Externí odkaz:
https://doaj.org/article/682ecd5165c944018af40436d7288bb8
Autor:
Feng Wang, Ming-Ming He, Zi-Xian Wang, Su Li, Ying Jin, Chao Ren, Si-Mei Shi, Bing-Tian Bi, Shuang-Zhen Chen, Zhi-Da Lv, Jia-Jia Hu, Zhi-Qiang Wang, Feng-Hua Wang, De-Shen Wang, Yu-Hong Li, Rui-Hua Xu
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Preclinical studies suggest synergistic effectiveness of ascorbic acid (AA, vitamin C) and cytotoxic agents in gastrointestinal malignancies. This phase 1 study aimed to establish the maximum tolerated dose (MTD) and recommended p
Externí odkaz:
https://doaj.org/article/aabd61cf0636479bbeed29831d4ccca0
Autor:
Rui-Hua Xu, Yu-Hong Li, Feng-Hua Wang, Dong-Sheng Zhang, Hui-Yan Luo, Shuang-Zhen Chen, Si-Mei Shi, Ying Guo, Hong Qiu, Zhi-Qiang Wang, Zong-Jiong Mai, Ying Jin, Xiang-Yuan Wu, Zeng-Qing Guo, Qing-Feng Zou, Ying Yuan, Jie-Er Ying, Fu-Xiang Zhou, Zhi-Xiang Zhuang, Yi-Chen Yao, Zhi-Gang Ma, Xiao-Hua Hu, Wei Wang, Yan Zhang, Wei-Jia Fang, Xiang-Lin Yuan, Yan-Qiao Zhang, Jian Xiao, Ming-Ming He, Feng Wang
Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b06772fe70faec5ac401fdfce8e7dbf
https://doi.org/10.1158/1078-0432.22488381.v1
https://doi.org/10.1158/1078-0432.22488381.v1
Autor:
Rui-Hua Xu, Yu-Hong Li, Feng-Hua Wang, Dong-Sheng Zhang, Hui-Yan Luo, Shuang-Zhen Chen, Si-Mei Shi, Ying Guo, Hong Qiu, Zhi-Qiang Wang, Zong-Jiong Mai, Ying Jin, Xiang-Yuan Wu, Zeng-Qing Guo, Qing-Feng Zou, Ying Yuan, Jie-Er Ying, Fu-Xiang Zhou, Zhi-Xiang Zhuang, Yi-Chen Yao, Zhi-Gang Ma, Xiao-Hua Hu, Wei Wang, Yan Zhang, Wei-Jia Fang, Xiang-Lin Yuan, Yan-Qiao Zhang, Jian Xiao, Ming-Ming He, Feng Wang
Supplementary Data from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ddb2013da603b76379f8a09fb0d76e8
https://doi.org/10.1158/1078-0432.22488387.v1
https://doi.org/10.1158/1078-0432.22488387.v1
Autor:
Fen Feng, Yu Hong Li, Wen hua Fan, Wei Wang, Zhen Hai Lu, Feng Wang, Rui-Hua Xu, Si mei Shi, Ying Jin, Zhi Qiang Wang, Feng Hua Wang, Pei-Rong Ding, Han lin Liang, De Shen Wang, Gong Chen, Yan Hong Deng, Chao Ren, Chuan bo Xie, Jianwei Zhang, Jie wen Peng
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 151-159 (2020)
Cancer Medicine
Cancer Medicine
Background Monosialotetrahexosylganglioside (GM1) is a neuroprotective glycosphingolipid that repairs nerves. Oxaliplatin‐based chemotherapy is neurotoxic. This study assessed the efficacy of GM1 for preventing oxaliplatin‐induced peripheral neur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4584c5d4a8f67b87ecb7f871b6936bce
https://doaj.org/article/682ecd5165c944018af40436d7288bb8
https://doaj.org/article/682ecd5165c944018af40436d7288bb8
Autor:
Feng Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Fu-Xiang Zhou, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng-Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(19)
Purpose: To compare the efficacy and safety of high-dose vitamin C plus FOLFOX ± bevacizumab versus FOLFOX ± bevacizumab as first-line treatment in patients with metastatic colorectal cancer (mCRC). Patients and Methods: Between 2017 and 2019, hist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf3ac8da86249a114a7d9658d64b072
https://pubmed.ncbi.nlm.nih.gov/35929990
https://pubmed.ncbi.nlm.nih.gov/35929990
Autor:
Niu Wang, Xiao Li Wei, Yun Xin Lu, De Shen Wang, Miao Zhen Qiu, Feng Hua Wang, Yu Hong Li, Zhi Qiang Wang, Si mei Shi, Rong jiao Wang, Rui-Hua Xu
Publikováno v:
OncoTargets and Therapy. 10:5065-5076
Trastuzumab has substantial antitumor activity in metastatic gastric cancer. One such mechanism by which it exerts its antitumor activity is antibody-dependent cell-mediated cytotoxicity, which has been reported to be influenced by FcγRIIA and IIIA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66ac3165fffec8a3549abdb14c476f58
https://doi.org/10.2147/ott.s142620
https://doi.org/10.2147/ott.s142620
Autor:
Jing Ping Yun, Miao Zhen Qiu, Hui Sheng, Si mei Shi, Rui-Hua Xu, Jing Wang, Hui Zhong Zhang, Da Jun Yang, Min Chen, Qi Nian Wu, Feng Hua Wang, Zhiwei Zhou
Publikováno v:
Journal of Cancer
Purpose: Patients with advanced or metastatic adenocarcinoma of the stomach or esophagogastric junction for whom trastuzumab therapy is being considered, assessment for tumor human epidermal growth factor receptor-2 (HER2) status is necessary. Can th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83fdd1d1525e2b0dfe9c24f4ce3cef3
http://europepmc.org/articles/PMC5687168
http://europepmc.org/articles/PMC5687168
Autor:
Ming-Ming He, Rui-Hua Xu, S. Chen, Zi-Xian Wang, Si-Mei Shi, Feng Wang, De Shen Wang, Ying Jin, Bing-Tian Bi, Jia-Jia Hu, Chao Ren, Su Li, Fenghua Wang, Zhi-Da Lv, Yu Hong Li, Zhi Qiang Wang
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background Preclinical studies suggest synergistic effectiveness of ascorbic acid (AA, vitamin C) and cytotoxic agents in gastrointestinal malignancies. This phase 1 study aimed to establish the maximum tolerated dose (MTD) and recommended phase 2 do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e0650c1bcebc932ed22228bfd45ac0
https://doi.org/10.1186/s12885-019-5696-z
https://doi.org/10.1186/s12885-019-5696-z
Autor:
Wang, Feng, He, Ming-Ming, Zi-Xian Wang, Li, Su, Jin, Ying, Ren, Chao, Si-Mei Shi, Bing-Tian Bi, Shuang-Zhen Chen, Zhi-Da Lv, Hu, Jia-Jia, Wang, Zhi-Qiang, Wang, Feng-Hua, De-Shen Wang, Li, Yu-Hong, Xu, Rui-Hua
Figure S2. Mean plasma concentration–time curve of ascorbic acid after fixed-rate infusions at 0.6, 0.8, 1.0 g/min to cancer patients. After i.v. administration, the plasma concentrations of ascorbic acid rose gradually and peaked at 3 h. Cmax, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366b84ee312511d2b3fd2f94d088be96